IW-3300 rectal foam + Placebo
Phase 2Terminated 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Interstitial Cystitis
Conditions
Interstitial Cystitis, Bladder Pain Syndrome
Trial Timeline
Mar 28, 2023 → Feb 6, 2025
NCT ID
NCT05740007About IW-3300 rectal foam + Placebo
IW-3300 rectal foam + Placebo is a phase 2 stage product being developed by Ironwood Pharmaceuticals for Interstitial Cystitis. The current trial status is terminated. This product is registered under clinical trial identifier NCT05740007. Target conditions include Interstitial Cystitis, Bladder Pain Syndrome.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05740007 | Phase 2 | Terminated |
Competing Products
20 competing products in Interstitial Cystitis